Medical genetics was revolutionized during the 1980s by the application of genetic mapping to locate the genes responsible for simple Mendelian diseases. Most diseases and traits, however, do not follow simple inheritance patterns. Geneticists have thus begun taking up the even greater challenge of the genetic dissection of complex traits. Four major approaches have been developed: linkage analysis, allele-sharing methods, association studies, and polygenic analysis of experimental crosses. This article synthesizes the current state of the genetic dissection of complex traits-describing the methods, limitations, and recent applications to biological problems.
Human genetics has sparked a revolution in medical science on the basis of the seemingly improbable notion that one can systematically discover the genes causing inherited diseases without any prior biological clue as to how they function. The method of genetic mapping, by which one compares the inheritance pattern of a trait with the inheritance patterns of chromosomal regions, allows one to find where a gene is without knowing what it is. The approach is completely generic, being equally applicable to spongiform brain degeneration as to inflammatory bowel disease.
To geneticists, this revolution is really nothing new. Genetic mapping of trait-causing genes to chromosomal locations dates back to the work of Sturtevant in 1913 (1) . It has been a mainstay of experimental geneticists who study fruit flies, nematode worms, yeast, and maize and who developed genetic maps containing hundreds of genetic markers that made it possible to follow the inheritance of any chromosomal region in a controlled cross. With the advent of recombinant DNA, genetic mapping was carried to its logical conclusion with the development of positional cloning-the isolation of a gene solely on the basis of its chromosomal location, without regard to its biochemical function. Positional cloning was invented by Bender and colleagues, who used it to isolate the bithorax complex in Drosophila (2) , and it rapidly became a routine technique in flies and worms.
Despite its central role in experimental organisms, genetic mapping hardly figured in the study of humans throughout most of the century. There were two reasons: the lack of an abundant supply of genetic markers with which to study inheritance, and the inability to arrange human crosses to suit experimental purposes. The key breakthrough was the recognition that naturally occurring DNA sequence variation provided a virtually unlimited supply of genetic markers-an idea first conceived of by Botstein and colleagues for yeast crosses (3) and subsequently for human families (4) . With highly polymorphic genetic markers, one could trace inheritance in existing human pedigrees as if one had set up the crosses in the laboratory. These ideas soon led to an explosion of interest in the genetic mapping of rare human diseases having simple Mendelian inheritance. More than 400 such diseases have been genetically mapped in this manner, and nearly 40 have been positionally cloned (5) .
Human geneticists are now beginning to explore a new genetic frontier, driven by an inconvenient reality: Most traits of medical relevance do not follow simple Mendelian monogenic inheritance. Such "complex" traits include susceptibilities to heart disease, hypertension, diabetes, cancer, and infection. The genetic dissection of complex traits is attracting many investigators with the promise of shedding light on old problems and is spawning a variety of analytical methods. The emerging issues turn out to be relevant not just to medical genetics, but to fundamental studies of mammalian development and applied work in agricultural improvement. The field is still at an early stage, but it is ready to explode much as it has done in recent years with the analysis of simple traits. The purpose of this article is to synthesize the key challenges and methods, to highlight some enlightening examples, and to identify further needs.
Complex Traits
The term "complex trait" refers to any phenotype that does not exhibit classic Mendelian recessive or dominant inheritance attributable to a single gene locus. In general, complexities arise when the simple correspondence between genotype and phenotype breaks down, either because the same genotype can result in different phenotypes (due to the effects of chance, environment, or interactions with other genes) or different genotypes can result in the same phenotype.
To some extent, the category of complex traits is all-inclusive. Even the simplest genetic disease is complex, when looked at closely. Sickle cell anemia is a classic example of a simple Mendelian recessive trait. Yet, individuals carrying identical alleles at the 3-globin locus can show markedly different clinical courses, ranging from early childhood mortality to a virtually unrecognized condition at age 50 (6) . The trait of severe sickle cell anemia is thus complex, being influenced by multiple genetic factors including a mapped X-linked locus and an inferred autosomal locus that can increase fetal hemoglobin amounts and thereby partially ameliorate the disease (7) .
It is often impossible to find a genetic marker that shows perfect cosegregation with a complex trait. The reasons for this can be ascribed to a few basic problems.
Incomplete penetrance and phenocopy. Some individuals who inherit a predisposing allele may not manifest the disease (incomplete penetrance), whereas others who inherit no predisposing allele may nonetheless get the disease as a result of environmental or random causes (phenocopy). Thus, the genotype at a given locus may affect the probability of disease, but not fully determine the outcome. The penetrance function f(G), specifying the probability of disease for each genotype G, may also depend on nongenetic factors such as age, sex, environment, and other genes. For example, the risk of breast cancer by ages 40, 55, and 80 is 37%, 66%, and 85% in a woman carrying a mutation at the BRCA1 locus as compared with 0.4%, 3%, and 8% in a noncarrier (8) . In such cases, genetic mapping is hampered by the fact that a predisposing allele may be present in some unaffected individuals or absent in some affected individuals.
Genetic (or locus) heterogeneity. Mutations in any one of several genes may result in identical phenotypes, such as when the genes are required for a common biochemical pathway or cellular structure. This poses no problem in experimental organisms, because geneticists can arrange to work with pure-breeding strains and perform crosses to assign mutations to complementation classes. In contrast, medical geneticists typically have no way to know whether two patients suffer from the same disease for different genetic reasons, at least until the genes are mapped. Examples of genetic heterogeneity in humans include polycystic kidney disease (9) , early-onset Alzheimer's disease (10) , maturity-onset diabetes of the young (11) , hereditary nonpolyposis colon cancer (12) , ataxia telangiectasia (13) , and xeroderma pigmentosum (14) . Retinitis pigmentosa, involving retinal degeneration, apparently can result from mutations in any of at least 14 different loci (15) , and Zellweger syndrome, involving the failure of peroxisome biosynthesis, from mutations in any of 13 loci (16) Polygenic inheritance is easily demonstrated in animal crosses, in the transmission pattern of quantitative traits such as blood pressure (17) , and in the pervasive "genetic background" effects that represent the action of modifier genes. For example, a mutation in the mouse Apc gene causes numerous intestinal neoplasias and early death in B6 mice but has barely noticeable effects when bred into an AKR strain (18) . More generally, the phenotype of "knockout mice" may vary dramatically on different strain backgrounds, pointing to previously unknown interacting genes.
Polygenic inheritance is harder to demonstrate directly in humans, but it is surely no less common. One form of retinitis pigmentosa was shown to be due to strict digenic inheritance, requiring the presence of heterozygous mutations at the peripherin/ RDS and ROM] genes (19) (whose encoded proteins are thought to interact in the photoreceptor outer segment disc membranes). Some forms of Hirschsprung disease appear to require the simultaneous presence of mutations on chromosomes 13, 21, and possibly elsewhere (20) . Polygenic inheritance complicates genetic mapping, because no single locus is strictly required to produce a discrete trait or a high value of a quantitative trait [except in the case of a pure synthetic interaction causing a discrete trait (21, 22) ].
High frequency of disease-causing alleles. Even a simple trait can be hard to map if disease-causing alleles D occur at high frequency in the population. The expected Mendelian inheritance pattern of disease will be confounded by the problem that multiple independent copies of D may be segregating in the pedigree [often referred to as bilineality (23) ] and that some individuals may be homozygous for D [in which case one will not observe linkage between D and a specific allele at a nearby genetic marker, because either of the two homologous chromosomes could be passed to an affected offspring (24) ]. Late-onset Alzheimer's disease provides an excellent example. Initial linkage studies found weak evidence of linkage to chromosome 19q, but they were dismissed by many observers because the lod score (logarithm of the likelihood ratio for linkage) remained relatively low, and it was difficult to pinpoint the linkage with any precision (25) . The confusion was finally resolved with the discovery that the apolipoprotein E type 4 allele appears to be the major causative factor on chromosome 19. The high frequency of the allele (-16% in most populations) had interfered with the traditional linkage analysis (26) . High frequency of disease-causing alleles becomes an even greater problem if genetic heterogeneity is also present.
Other transmission mechanisms. Finally, mammalian genetics has revealed additional modes of genetic inheritance. These include mitochondrial inheritance (in which mitochondria pass solely through the material germ line, and each meiotic transmission may involve selection from a potentially mixed population of mutant and normal organelles); imprinting (due to differential activity of the paternal and maternal copies of a gene); and phenomena due to the expansion of trinucleotide repeats such as so-called "anticipation." These modes of transmission pose little difficulty when they obey strict rules (as for imprinting), but they can complicate analysis when they lead to highly variable transmission rates [as for some mitochondrial diseases or trinucleotide repeat diseases (27) ] and may require specialized methods (28) .
Genetic Epidemiology
Before undertaking DNA-based studies aimed at genetic dissection, one would ideally like to infer as much as possible about the genetic basis of a trait on the basis of the pattern of disease incidence in families and populations. Such genetic epidemiology constitutes a major field in its own right for which excellent reviews exist (29) . We focus on a few key concepts.
Twin studies. Whereas experimental geneticists can propagate inbred lines with isogenic genetic constitution, the only opportunity to examine the expression of a human trait in a fixed genetic background comes from the study of monozygotic (MZ) twins (30) (42) . In studying hypertension, one can increase X by focusing on cases with combined hypertension and hyperlipidemia (43 (35, 36) . Hereditary nonpolyposis colon cancer (12) (DataIM1)/Prob (Data M0), or, equivalently, by the lod score, Z = logl(LR) (49, 50 (50, 52) , although the appropriateness of this choice is discussed in the section on statistical significance.
Applications. Linkage analysis is the current workhorse of human genetic mapping, having been applied to hundreds of simple monogenic traits. Linkage analysis has also been successfully applied to genetically heterogeneous traits in some cases. The simplest situation is when unequivocal linkage can be demonstrated in a single large pedigree (with Z >> 3), even though other families may show no linkage. This has been done for such diseases as adult polycystic kidney disease, early-onset Alzheimer's disease, and psoriasis (53) . If linkage cannot be established on the basis of any single pedigree, one can ask whether a subset of the pedigrees collectively shows evidence of linkage. Of course, one cannot simply choose those families with positive lod scores and exclude those with negative lod scores, as such an ex post selection criterion will always produce a high positive lod score. Instead, one must explicitly allow for genetic heterogeneity within the linkage model (through the inclusion of an admixture parameter ot specifying the proportion of linked families), although care is required because the resulting lod score has irregular statistical properties (54) . Alternatively, families can be selected on the basis of a priori considerations. An example of this approach is provided by the genetic mapping of a gene for early-onset breast cancer (BRCA1) to chromosome 17q (55) . Families were added to the linkage analysis in order of their average age of onset, resulting in a lod score that rose steadily to a peak of 2 = 6.0 with the inclusion of families with onset before age 47 and then fell with the addition of later-onset pedigrees. Notwithstanding these successes, many failed linkage studies may result from cryptic heterogeneity. It is always wise to try to redefine traits to make them more homogeneous.
Linkage analysis can also be applied when penetrance is unknown. One approach is to estimate the ML value of the penetrance p within the linkage analysis. A particular concern is to avoid incorrectly overestimating p, because this can lead to spurious evidence against linkage (caused by individuals who inherit a trait-causing allele but are unaffected). One can guard against this problem by performing an affecteds-only analysis, in which one records unaffected individuals as "phenotype unknown" or, equivalently, sets the penetrance artificially low (p --0). This approach was important in studies of both early-onset and late-onset Alzheimer's disease (25, 56) . In the latter case, the lod score increased from 2.20 with an age-adjusted penetrance function to 4.38 with an affecteds-only analysis.
Some traits are so murky that it is unclear who should be considered affected. Psychiatric disorders fall into this category, and investigators have explored using various alternative diagnostic schemes within their analysis. For example, schizophrenia might be defined strictly to include only patients meeting the Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria or be defined more loosely to include patients with so-called schizoid personality disorders (57) . This approach is permissible in theory but requires great care in adjusting the significance level to offset the effect of multiple hypothesis testing.
Linkage analysis can also be extended to situations in which two or more genes play a role in the inheritance of a disease, simply by examining the inheritance pattern of pairs of regions. Such an approach has been dubbed simultaneous search (21, 58, 59) . It can be applied to the situation of a genetically heterogeneous trait or to an interaction between two loci. Multiple sclerosis in large Finnish kindreds has been reported to be linked to the inheritance of both HLA on chromosome 6 and the gene for myelin basic protein on chromosome 18, on the basis of such a two-locus analysis (60) .
Limitations. Linkage analysis is subject to the same limitations as any model-based method. It can be very powerful, provided that one specifies the correct model (61, 2040 62). Use of the wrong model, however, can lead one to miss true linkages and sometimes to accept false linkages (63, 64) . In particular, exclusion mapping of regions can only demonstrate absence of a trait-causing locus fitting the particular model tested (50, 52) . Finally, testing many models requires the use of a higher significance level, which may decrease the power to detect a gene; this issue is discussed in the section on statistical significance. The more complex the trait, the harder it is in general to use linkage analysis (65) .
Computation. Calculating the likelihood ratio can be horrendously complicated in some cases and requires computer programs (66, 67) . Elston and Stewart invented the first practical algorithm for calculating likelihoods (68, 69) , which was implemented by Ott in the first general-purpose linkage program LIPED (70) and is also at the heart of the widely used LINKAGE package (71) . However, the algorithm is not a complete panacea. In its original form it does not easily accommodate environmental or polygenic covariation among family members, which form the basis of so-called "mixed models" (67, 72) used widely in genetic epidemiology (73) . In addition, it can be extremely slow for analysis with many genetic markers or inbred families. Alternative exact algorithms have been developed for some applications (74) , including one that allows multipoint homozygosity mapping (75) , but these tend to be limited to smaller pedigrees. Likelihoods can also be estimated by simulation-based methods, such as the Gibb's sampler and Monte Carlo Markov chains (76) . There remain many important computational challenges in linkage analysis.
Allele-Sharing Methods
Allele-sharing methods are not based on constructing a model, but rather on rejecting a model. Specifically, one tries to prove that the inheritance pattern of a chromosomal region is not consistent with random Mendelian segregation by showing that affected relatives inherit identical copies of the region more often than expected by chance (Fig. 2) . Because allele-sharing methods are nonparametric (that is, assume no model for the inheritance of the trait), they tend to be more robust than linkage analysis: affected relatives should show excess allele sharing even in the presence of incomplete penetrance, phenocopy, genetic heterogeneity, and high-frequency disease alleles. The tradeoff is that allele-sharing methods are often less powerful than a correctly specified linkage model.
Allele-sharing methods involve studying affected relatives in a pedigree to see how often a particular copy of a chromosomal (79) (80) (81) .
Sib pair studies have played an important role in the study of type I diabetes. Excess allele sharing confirmed the important role of HLA, although the inheritance pattern fit neither a simple dominant or recessive model (82, 83) . With the availability of a comprehensive human genetic Allele-sharing methods Fig. 2 . Allele-sharing methods involve testing whether affected relatives inherit a region identical-by-descent (IBD) more often than expected under random Mendelian segregation. Affected sib pair analysis is a well-known special case, in which the presence of a trait-causing gene is revealed by more than the expected 50% IBD allele sharing. The method is more robust for genetic complications than linkage analysis but can be less powerful than a correctly specified linkage model. Examples include applications to type diabetes, essential hypertension, IgE levels, and bone density in postmenopausal women. linkage map, sib pair analysis has been applied to a whole-genome scan, and excess allele sharing has been found at a locus on chromosome 1 q, pointing to a previously unidentified causal factor in type I diabetes (84) . In a similar search restricted to the X chromosome, brothers concordant for the trait of homosexual orientation showed significant excess allele sharing (33 out of 40 cases) in the region Xq28, suggesting the involvement of a genetic factor influencing at least the particular subtype of homosexuality studied (85) (25) .
Quantitative traits. Allele-sharing methods can also be applied to quantitative traits. An approach proposed by Haseman and Elston (89) is based on the notion that the phenotypic similarity between two relatives should be correlated with the number of alleles shared at a trait-causing locus. Formally, one performs regression analysis of the squared difference A2 in a trait between two relatives and the number x of alleles shared IBD at a locus. The approach can be suitably generalized to other relatives (90) and multivariate phenotypes (91) . It has been used, for example, to relate serum IgE levels with allele sharing in the region of the gene encoding interleukin-4 and bone density in postmenopausal women with allele sharing in the region of the vitamin D receptor (92, 93) . In addition, there has been a resurgence of interest in the theoretical aspects of mapping genes with IBD and IBS methods (94) .
APM methods have been applied to whole-genome searches only in a few cases, including a recent study on manic depression (95) . This situation is certain to change in the near future.
Association Studies
Association studies do not concern familial inheritance patterns at all. Rather, they are case-control studies based on a comparison of unrelated affected and unaffected individuals from a population (Fig. 3 ). An 3) Most disturbingly, positive association can also arise as an artifact of population admixture. In a mixed population, any trait present at a higher frequency in an ethnic group will show positive association with any allele that also happens to be more common in that group. To give a lighthearted example, suppose that a would-be geneticist set out to study the "trait" of ability to eat with chopsticks in the San Francisco population by performing an association study with the HLA complex. 3) Once a tentative association has been found, it should be subjected to a transmission disequilibrium test (TDT) (104, 105) . The test has the premise that a parent heterozygous for an associated allele Al and a nonassociated allele A2 should more often transmit A, than A2 to an affected child. The TDT was first applied to the puzzling situation of the insulin gene, which showed strong association but no 2042 linkage to type I diabetes; linkage had been obscured because of the substantial proportion of homozygous (and thus nonsegregating) parents (104) . It should be noted that TDT cannot be directly applied to the sample in which initial association was found (because affected individuals necessarily have an excess of the associated allele) but rather to a new sample from the same population.
The controversy over a reported association between alcoholism and an allele at the dopamine D2 receptor (DRD2) illustrates all the issues in association studies. The initial study compared postmortem samples from 35 ( 108) . At present, there is no compelling evidence that the reported association is not an artifact of admixture.
Association studies are not well suited to whole-genome searches in large, mixed populations. Because linkage disequilibrium extends over very short distances in an old population (109) , one would need tens of thousands of genetic markers to "cover" the genome. Moreover, testing many markers raises a serious problem of multiple hypothesis testing: each association test is nearly independent. Testing n loci each with k alleles amounts to performing about n(k-1) independent tests, and the required significance level should be divided by this factor. A nominal significance level of P 0.0001 is thus needed simply to achieve an overall false positive rate of 5%, if one tests 100 markers with six alleles each. (Some authors propose to avoid this problem by identifying all results significant at the P = 0.05 level in an initial sample and then attempting to replicate them in a second sample (110) . However, the same multiple testing issue still applies to retesting many results at the second stage.) Genomic search for association may be more favorable in young, genetically isolated populations because linkage disequilibrium extends over greater distances, and the num-SCIENCE * VOL. 265 * 30 SEPTEMBER 1994 ber of disease-causing alleles is likely to be fewer (21, 111 Experimental crosses of mice and rats offer an ideal setting for genetic dissection of mammalian physiology (Fig. 4) . With the opportunity to study hundreds of meioses from a single set of parents, the problem of genetic heterogeneity disappears, and far more complex genetic interactions can be probed than is possible for human families. Animal studies are thus an extremely powerful tool for extending the reach of genetic analysis. Of course, animal studies must always be evaluated for their applicability to the study of human diseases. Because disease-causing mutations may occur at many steps in a pathway, animal models may not point to those genes most frequently mutated in human disease. However, animal studies should identify key genes acting in the same biochemical pathway or physiological system. Animal models that are poor models for pharmacologists seeking to evaluate a new human drug therapy may nonetheless be excellent models for geneticists seeking to elucidate the possible molecular mechanisms or pathways affected in a disease. The power of experimental crosses is most dramatically seen in the ability to dissect quantitative traits into discrete genetic factors (1 12) . Systematic quantitative trait locus (QTL) mapping has only recently become possible with the construction of dense genetic linkage maps for mouse and rat (18, 113, 114) (59, 115, 116) . In general, QTL mapping is much more powerful in experimental crosses than in human families because of the fundamental differences in the statistical comparisons involved (1 17) and because nongenetic noise can be decreased through the use of progeny tests, recombinant inbred strains, and recombinant congenic strains (47, 118) .
Genome-wide QTL analysis was first applied to fruit characteristics in the tomato (119) , but it was soon used in mammals to study epilepsy in mice and hypertension in rats (1 13, 120) . In the latter case, the animal study rapidly stimulated parallel human studies, with the reported linkage of the ACE gene to hypertension in rats provoking investigation of various genes in the pathway and leading to the implication of angiotensinogen in essential hypertension in humans. In only a short time, there has been an explosion of interest in QTL mapping in both agriculture and biomedicine (121) . The approach opens the way to understanding the genetic basis for the tremendous strain variations seen in such quantitative traits as cancer susceptibility, drug sensitivity, resistance to infection, and aggressive behavior (122 (18) . By applying this approach to the ever-growing list of gene knockouts, it should be possible to identify many additional interacting genes.
Experimental crosses also facilitate analysis of discrete traits with complex genetic etiology. Studies of type I diabetes in the nonobese diabetic mouse report the mapping of a dozen loci, each making a partial contribution to a threshold trait (123) . Analysis of type I diabetes in the BB rat points to a purely synthetic interaction with one, two, or three genes required to produce disease, depending on the particular cross (124) .
After initial mapping, experimental geneticists can study the physiological effects of individual polygenic factors by constructing congenic strains that differ only in the region of a single locus. Genes may also be mapped more finely by systematically whittling away at the size of the congenic interval. In some cases, synteny conservation in gene order between different mammals may point to interesting regions to investigate in the human genome.
An important point about the use of experimental crosses deserves to be emphasized, because it is commonly misunderstood. Genetic mapping results need not be consistent among different crosses. Linkage analysis reveals only those trait-causing genes that differ between the two parental strains used. A QTL may thus be detected in an A X B cross, but not in an A X C cross. Moreover, the effect of a QTL allele may change-or even disappear-when bred onto a different genetic background, because of epistatic effects of other genes.
Statistical Significance
One of the thorniest problems in the genetic analysis of complex traits is to know whether a result is statistically significant. Psychiatric genetics has confronted this issue most squarely, as reported linkages to manic depression or schizophrenia have typically failed to withstand close scrutiny or replication (57, 125) . Statistical significance is a challenging problem because genetic analysis can involve two types of fishing expeditions: testing many chromosomal Experimental crosses Fig. 4 . Experimental crosses can provide a large number of progeny while ensuring genetic homogeneity. As a result, experimental crosses permit the genetic dissection of more complex genetic interactions than directly possible in human families, such as mapping of QTLs. Examples include epilepsy in mice, hypertension in rats, type diabetes in mice and rats, and susceptibility to intestinal cancer in mice.
regions across a genome and testing multiple models for inheritance.
For example, human geneticists have long used the convention that a lod score exceeding 3 should be required to declare linkage to a simple Mendelian trait. The threshold was based on a Bayesian argument involving the prior probability of finding a gene and aimed to yield a false positive rate of 5%. Unfortunately, the reasoning does not extend well to the modern world of complex traits (with no clear prior hypothesis) or dense maps (with thousands of markers that can be tested). Instead, two approaches have gained favor in recent years.
Analytical methods. Formally speaking, genetic dissection involves calculating a statistic X throughout a genome. The issue of statistical significance consists of choosing an appropriate threshold T for declaring the presence of a gene, such that the genome-wide false positive rate, Prob (X > T), is small, under the null hypothesis that no gene is present. In some cases, the genome-wide false positive rate can be estimated on the basis of simple and elegant mathematical formulas. The unifying idea comes from the insight (47, 126) that many linkage statistics tend to an asymptotic null distribution that is closely related to a wellknown physical process called the Ornstein-Uhlenbeck diffusion (which describes the velocity of a particle undergoing onedimensional Brownian motion). The problem of random large excursions of such diffusions has been extensively studied and applies directly to genetic analysis. The genome-wide false positive rate, oLT* = Prob (X > T somewhere in the genome), can be related to the nominal false positive rate, OT = Prob (X > T at a single point), by the formula
where C is the number of chromosomes, G is genetic length of the genome in Morgans, and the constant p and the function h(T) are defined in the notes (127) . Solving OfT* = 0.05 yields the appropriate threshold T. As confirmed by simulation studies, the estimates apply well to many basic situations (47, 128) . Appropriate thresholds for various settings are shown in Table 1 . For traditional human linkage analysis, the appropriate asymptotic lod score threshold for a 5% significance level is about 3.3. The traditional threshold of 3 actually yields a genome-wide false positive rate of about 9%. Note that all of the thresholds correspond to nominal p values less than 1o-4; this is considerably more stringent than the level of 10-3 applied by many authors.
The problem of searching over alternative models has received formal attention in only a few cases (61) . Current practice is to consider that each of the k models examined are statistically independent. The traditional Bonferroni correction prescribes multiplying the significance level by k or, equivalently, increasing the required lod score threshold by about log1o(k) (129) .
The approach will likely be too conservative if the models are dependent.
Simulation studies. Unfortunately, the analytical approach depends on key assumptions (such as the normality of an underlying statistic and the pooling of many independent meioses) which will often be false in important situations, for example, affected-pedigree-member (APM) analysis of a modest number of large pedigrees. The best approach in such cases is to directly estimate the false positive rate by simulation. In most settings, one can randomly generate the inheritance pattern of genetic markers in a pedigree according to the laws of Mendelian inheritance and then recalculate the value of the statistic X for each such replicate (61, 130) . In some settings, one can apply permutation tests such as scrambling the phenotypes or genotypes in a sib pair or QTL analysis (131). Simulation-based tests have received a great deal of attention in statistics in general (132) and are very appropriate for many genetic analyses settings (61, 130, 131) . They have been applied to the problem of genome-wide search and model selection (61) . We strongly advocate this approach, although broad use will require increased dissemination of computer programs for simulation analysis.
A final issue should be noted. The appropriate thresholds for whole-genome searches should always be applied to any new hypothesis, even if one only searches over a small subset of the genome. The reason is that traits of interest will typically be studied by multiple investigators, but only positive results will be published. The genetics community as a whole is thus conducting a whole-genome scan, and the full multiple testing threshold should be applied to any positive result. Some authors have suggested avoiding this problem by developing hypotheses in one data set and retesting them in another (133). This can be helpful, but one must still apply a correction if one expects to retest multiple hypotheses at the second stage.
Experimental Design
In designing a genetic dissection, two crucial choices arise: (i) the number and type of families from which to collect data and (ii) the number and type of genetic markers to use. To make these choices, one needs to Table 1 . Asymptotic thresholds corresponding to a genome-wide significance level of 5%. The human applications pertain to linkage analysis in a pedigree without many missing individuals and to the most common types of affected-relative pair analysis. For sib pairs, two cases are considered: (i) parents available for typing, with allele sharing on maternal and paternal chromosomes counted separately, and (ii) parents unavailable for typing, in which case sibs share zero, one, or two copies and the possible triangle method is applied [see (81) ]. The mouse applications pertain to situations such as QTL mapping, in which either a single parameter is estimated (for example, an additive effect) or two parameters are estimated (for example, independent additive and dominant effects). Two-sided tests are used to allow for either parental strain to contribute alleles that increase the trait. Asymptotic thresholds correspond to the situation of a dense genetic map applied to a large number of meioses. Equivalent thresholds are given in terms of lod scores; normal scores used in allele-sharing methods and QTL mapping [that is, standard random normal variables (Z) (21, 134) . More generally, the power to detect linkage depends essentially on the number of informative meioses, almost regardless of family structure. Power can be approximated simply by counting informative meioses and can be more precisely estimated with simulation-based computer packages such as SIMLINK and SLINK (135).
In contrast, there is no comparable prescription for a complex trait. The optimal experimental design depends on the precise details of the genetic complexities, information which is typically not known in advance. The best compromise is to design a study to have sufficient power to detect any genes with effects exceeding a given magnitude. For example, one can calculate the number of sib pairs required to use allelesharing methods to detect a locus that increases the relative risk to siblings by at least twofold (32, 82, 136) . However, even if the overall relative risk to siblings is large, there is no guarantee that there exists any individual locus having an effect of this magnitude. Similarly, one can calculate the number of progeny needed to detect a QTL accounting for 10% of the phenotypic variance of a trait, but predicting whether any such loci will be present is possible only under very favorable circumstances (137) . Genetic analyses of complex traits should always explicitly report the minimum effect that could have been reliably detected given the subjects studied.
The optimal choice of which families or crosses to study may also vary with the circumstances. For human studies, the range of choices include whether to focus on individuals with extreme phenotypes, when to extend a pedigree, and whether to prefer or to exclude families with too many affected individuals (137) . For animal studies, the issues include whether to set up a backcross or intercross and whether to concentrate on the progeny with the most extreme phenotypes (47, 138) .
The optimal density of genetic markers is a topic requiring more attention. The effect of polymorphism rate on the power of allele-sharing methods has been studied for single markers (33, 95, 136, 139) (47, 140) . Finally, a few authors have begun to explore two-tiered strategies, in which initial evidence is obtained with a sparse map and then confirmed with a dense map (141 (143) .
For complex traits, positional cloning will likely be even harder. Because cosegregation is not expected to be perfect, single crossovers no longer suffice for fine-structure mapping. Resolution becomes a statistical matter (144) . For a gene conferring a relative risk of twofold, for example, one would need to examine a median number of nearly 600 sib pairs to narrow the likely region (95% confidence interval) to 1 cM. Moreover, the genes underlying complex traits may be subtle missense mutations rather than gross deletions. How will positional cloners overcome these obstacles?
In the human, the most powerful strategy may prove to be linkage disequilibrium mapping in genetically isolated populations (21, 145 (143) . Whereas conventional recombinational mapping was only able to localize the gene to within about 1.5 cM, linkage disequilibrium studies were able to pinpoint it to within about 50 kb. The approach is also applicable to younger populations: linkage disequilibrium should be detectable over larger distances, although the ultimate resolving power will be less (146) . Elegant studies in the Mennonite population (founded about 10 generations ago) have allowed initial mapping of genes involved in a recessive form of Hirschsprung disease (20) .
In animal models, fine-structure mapping of factors such as QTLs can be accomplished through appropriate breeding. The key is to ensure unambiguous genotyping at the trait-causing locus. The best solution is probably to (i) create congenic strains differing only in the region of interest, (ii) cross these strains to construct recombinant chromosomes (that is, ones in which there has been a crossover between flanking genetic markers), and (iii) evaluate each recombinant chromosome to determine which trait-causing allele is carried by performing progeny testing (that is, examining the phenotype of many progeny carrying the chromosome) (113) . The construction of the required congenic strains would traditionally require 20 generations of breeding. With the advent of complete genetic linkage maps, however, one can construct "speed congenics" in only three to four generations by using marker-directed breeding (147).
The Human Genome Project promises to make a tremendous contribution to the positional cloning of complex traits by eventually providing a complete catalog of all genes in a relevant region. With such information, positional cloning will be reduced to the systematic evaluation of candidate genes-still challenging, but far more manageable than today's more haphazard forays. Indeed, the Human Genome Project is essential if the genetic analysis of complex traits is to achieve its full potential.
Finally 
